The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) for the treatment of adults with locally advanced ...

Maria Eugenia Ferré Rangel, Chairwoman of the Board of Directors at GFR Media and Chief Communications Officer of Grupo Ferré Rangel, emphasized the importance of this partnership ...

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...

Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

Subgroup analyses included Vitamin K antagonist (VKA) vs. direct oral anticoagulant (DOAC); OAC with intravenous thrombolysis (IVT), for patients deemed appropriate, vs. EVT alone. 15 studies were ...

Evidence from 2,000-year-old DNA reveals that women in Celtic society stayed in their ancestral communities after marriage, whereas men were mobile, and that the southern coast of Britain was a ...